Ikeda S, Suzuki T, Kiyohara Y, Kuramochi A
Dept. of Dermatology, Saitama Medical School, Japan.
Gan To Kagaku Ryoho. 1993 Aug;20(10):1293-301.
In Japan the regimen with peplomycin has been mainly used for the treatment of squamous cell carcinoma (SCC). But recently, a regimen with cisplatin, particularly the combination of cisplatin and adriamycin (CA chemotherapy) has been used for the treatment of SCC, and a better prognosis has resulted Since CA chemotherapy is very effective for not only SCC, but also basal cell carcinoma (BCC), we think it is a prominent neoadjuvant therapy for SCC and BCC. We have used CA chemotherapy for multiple lung metastasis of BCC over the past six years, and three times PR was obtained, with survival so far.
在日本，培普利霉素方案主要用于治疗鳞状细胞癌（SCC）。但最近，顺铂方案，尤其是顺铂与阿霉素联合（CA化疗）已用于SCC的治疗，并取得了更好的预后。由于CA化疗不仅对SCC有效，对基底细胞癌（BCC）也有效，我们认为它是SCC和BCC一种显著的新辅助治疗方法。在过去六年中，我们已将CA化疗用于BCC的多发肺转移，三次获得部分缓解，患者至今存活。
